Deprescribing Antidepressants

Posted Thursday 13 February 2025 | Brisbane South Primary Health Network

The overuse of psychiatric medications has become a growing concern for key healthcare and regulatory bodies. Deprescribing is a positive, patient-centered intervention carried out under medical supervision. It involves reassessing the role of all medicines to determine if any should be stopped - whether they no longer provide clear benefits, may cause harm, are being used for a condition that is no longer relevant, or no longer align with the patient's current goals of care.

We invite you to attend an important webinar featuring Dr Mark Horowitz and Professor Katharine Wallis. This session will offer valuable insights and practical strategies for deprescribing. Dr Horowitz will provide valuable insights into how to use the evidence-based hyperbolic tapering approach to safely reduce or stop the use of psychotropic medications, whilst managing withdrawal symptoms and ensuring patient safety. Professor Wallis will discuss details of her RELEASE trial - an intervention designed to support people to safely stop antidepressants.

Speakers

• Dr Mark Horowitz, MBBS PhD.
• Professor Katharine Wallis, MBChB, PhD, MBHL, Dip Obst, FRNZCGP, FACRRM, GAICD.

Topics

• Deprescribing strategies.
• Managing withdrawal symptoms and ensuring patient safety.
• RELEASE Trial.